MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04598nam a22004695i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
978-0-387-22852-5 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250710083926.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100301s2005 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780387228525 |
| -- |
99780387228525 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/b99861 |
| Source of number or code |
doi |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.9041 |
| Edition information |
23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gould, Ian M. |
| Relator term |
editor. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Antibiotic Policies |
| Medium |
[recurso electrónico] : |
| Remainder of title |
Theory and Practice / |
| Statement of responsibility, etc. |
edited by Ian M. Gould, Jos W. M. Meer. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Boston, MA : |
| Name of producer, publisher, distributor, manufacturer |
Springer US, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2005. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XIV, 766 p. |
| Other physical details |
online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
recurso en línea |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Antibiotic Policies-A Historical Perspective -- Guideline Implementation: It is Not Impossible -- UK Guidelines: Methodology and Standards of Care -- Pneumonia Guidelines in Practice -- Collecting, Converting, and Making Sense of Hospital Antimicrobial Consumption Data -- How Do Measurements of Antibiotic Consumption Relate to Antibiotic Resistance? -- Quantitative Measurement of Antibiotic Use -- Benchmarking -- Experiences with Antimicrobial Utilisation Surveillance and Benchmarking -- Interventions to Optimise Antibiotic Prescribing in Hospitals: The UK Approach -- Improving Prescribing in Surgical Prophylaxis -- Audits for Monitoring the Quality of Antimicrobial Prescriptions -- Multidisciplinary Antimicrobial Management Teams and the Role of the Pharmacist in Management of Infection -- Antibiotic Policy-Slovenian Experiences -- Intensive Care Unit -- The Real Cost of MRSA -- Antifungal Agents: Resistance and Rational Use -- Strategies for the Rational Use of Antivirals -- Disinfection Policies in Hospitals and the Community -- The Evolution of Antibiotic Resistance within Patients -- Impact of Pharmacodynamics on Dosing Schedules: Optimizing Efficacy, Reducing Resistance, and Detection of Emergence of Resistance -- Types of Surveillance Data and Meaningful Indicators for Reporting Antimicrobial Resistance -- Data Mining to Discover Emerging Patterns of Antimicrobic Resistance -- Applications of Time-series Analysis to Antibiotic Resistance and Consumption Data -- Biocide Use and Antibiotic Resistance -- Interventions to Improve Antibiotic Prescribing in the Community -- Education of Patients and Professionals -- The Influence of National Policies on Antibiotic Prescribing -- Antibiotic Use in the Community -- Antibiotic Use in the Community: The French Experience -- Antibiotic Policies in Developing Countries -- Antimicrobial Resistance and its Containment in Developing Countries -- Antibiotic Use in Animals-Policies and Control Measures Around Europe -- The Pharmaceutical Company Approach to Antibiotic Policies -- Antibiotic Use-Ecological Issues and Required Actions. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
For 50 years, antibiotics have been dispensed like sweets. This must not be allowed to continue. This unique book assembles contributions from experts around the world concerned with responsible use of antibiotics and the consequences of overuse. For the first time, it provides up to the minute texts on both the theoretical aspects of antibiotic stewardship and the practical aspects of its implementation, with consideration of the key differences between developed and developing countries. All concerned with teaching, practice and administration of clinical medicine, surgery, pharmacy, public health, clinical pharmacology, microbiology, infectious diseases and clinical therapeutics will find Antibiotic Policies: Theory and Practice essential reading. Antibiotic use and resistance is not just the responsibility of specialists in the field but the responsibility of all doctors, pharmacists, nurses, healthcare administrators, patients and the general public. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
MEDICINE. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
MICROBIOLOGY. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
TOXICOLOGY. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
EMERGING INFECTIOUS DISEASES. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
BIOMEDICINE. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
MEDICAL MICROBIOLOGY. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
INFECTIOUS DISEASES. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
PUBLIC HEALTH/GESUNDHEITSWESEN. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
PHARMACOLOGY/TOXICOLOGY. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
MICROBIOLOGY. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Meer, Jos W. M. |
| Relator term |
editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Printed edition: |
| International Standard Book Number |
9780306485008 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="http://dx.doi.org/10.1007/b99861">http://dx.doi.org/10.1007/b99861</a> |
| Public note |
Ver el texto completo en las instalaciones del CICY |
| 912 ## - |
|---|
| -- |
ZDB-2-SBL |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Libros electrónicos |
